A consensus on the diagnosis and treatment of acromegaly complications

 
Thumbnail
View/Open
Author
Melmed, S.
Casanueva, F. F.
Klibanski, A.
Bronstein, M. D.
Chanson, P.
Lamberts, S. W.
Strasburger, C. J.
Wass, J. A. H.
Giustina, A.
Published Version
https://doi.org/10.1007/s11102-012-0420-x
Metadata
Show full item record
Citation
Melmed, S., F. F. Casanueva, A. Klibanski, M. D. Bronstein, P. Chanson, S. W. Lamberts, C. J. Strasburger, J. A. H. Wass, and A. Giustina. 2012. “A consensus on the diagnosis and treatment of acromegaly complications.” Pituitary 16 (1): 294-302. doi:10.1007/s11102-012-0420-x. http://dx.doi.org/10.1007/s11102-012-0420-x.
Abstract
In March 2011, the Acromegaly Consensus Group met to revise and update the guidelines on the diagnosis and treatment of acromegaly complications. The meeting was sponsored by the Pituitary Society and the European Neuroendocrinology Association and included experts skilled in the management of acromegaly. Complications considered included cardiovascular, endocrine and metabolic, sleep apnea, bone diseases, and mortality. Outcomes in selected, related clinical conditions were also considered, and included pregnancy, familial acromegaly and invasive macroadenomas. The need for a new disease staging model was considered, and design of such a tool was proposed.
Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730092/pdf/
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:11855918

Collections